The Dow Jones and S&P 500 posted robust gains Friday afternoon. Nvidia led the Dow and Ulta topped the S&P 500 on the stock ...

We recently compiled a list of the 10 Stocks With At Least $30 Million In Insider Spending Recently. In this article, we are ...

Shares of iBio Inc. IBIO rallied 9.95% to $6.41 Monday, on what proved to be an all-around poor trading session for the stock market, with the NASDAQ Composite Index COMP falling 2.64% to 18,350.19 ...

$IBIO insiders have traded $IBIO stock on the open market 7 times in the past 6 months. Of those trades, 7 have been purchases and 0 have been sales.

The firm currently has a sector outperform rating on the real estate investment trust’s stock. Other equities analysts have also issued reports about the stock. Wedbush upgraded shares of Wellto ...

Revenue reached $105 million, outpacing the $99.5 million forecast. In response, PAR Technology's stock surged 13.26% in pre-market trading, reflecting investor enthusiasm. According to ...

HealthEquity (NASDAQ:HQY – Get Free Report) had its price target upped by stock analysts at Wells Fargo & Company from $110.00 to $125.00 in a research report issued on Wednesday,Benzinga reports.

Nvidia’s datacenter unit, which encompasses the company’s graphics processing units (GPUs) powering most generative AI models, brought in $35.6 billion in sales, smashing forecasts of $33.5 ...

This is indicative of how bonkers this Oscar season has been: One of the best picture contenders begins with a series of strip club lap dances, another ends with a monstrous amount of blood being ...

Explore Brazil Potash stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for GRO. Brazil Potash Stock Could Double: Analyst Bets On Autazes' Strategic Role In ...

U.S. stock futures are pointing higher after indexes declined again Tuesday; Nvidia (NVDA) stock is advancing ahead of its highly anticipated quarterly report after the bell; Super Micro Computer ...

The company's revenue also missed expectations, coming in at $349.8 million against a forecast of $351.35 million. Despite these misses, the stock showed resilience, trading up slightly by 0.04% ...